Latin America Market Entry Guide for Indian Herbal Ingredient Suppliers

Latin America is not one herbal ingredient market. It is at least nine of them, and the two that matter most to an Indian exporter right now, Brazil and Mexico, do not regulate botanicals the same way, do not trade with India on the same terms, and are not even moving in the same direction on tariffs. Suppliers who treat the region as a single opportunity tend to discover the differences the expensive way, after a shipment is held at a Brazilian port or a product notification is rejected in Mexico City for using the wrong classification.

This guide focuses on the two anchor markets, Brazil and Mexico, with a comparison table for the structural differences that matter most, and a brief look at where Colombia, Argentina, and Chile fit for suppliers planning further out.

Why Brazil and Mexico first

Brazil and Mexico are Latin America’s two largest consumer markets for nutraceuticals and dietary supplements, and they are the two countries where an Indian exporter is most likely to find an established import infrastructure, including freight forwarders, customs brokers, and regulatory consultancies who already work with botanical ingredients. Colombia, Argentina, and Chile are real markets, but they are typically a second-wave decision once a supplier has working relationships and a track record in the region.

The two countries could not be more different in how they get a botanical ingredient onto a shelf.

Brazil: a positive list system with a living list

Brazil regulates herbal ingredients as suplementos alimentares, food supplements, under the National Health Surveillance Agency, ANVISA. The foundational rule is RDC No. 243/2018, with the actual list of authorized constituents, their use limits, and permitted claims set out in Normative Instruction No. 28/2018 and its many subsequent amendments.

That list is genuinely a living document. In the eighteen months before this guide was written, ANVISA amended it repeatedly, including Normative Instruction No. 373/2025, No. 418, No. 431 in April 2026, and No. 452 in June 2026. Each amendment can add new authorized constituents, adjust maximum daily intake levels, or revise permitted claims. A supplier who checked the list a year ago and found their ingredient absent should check again, since the list moves faster than most regulatory frameworks in the region.

The practical path splits in two:

If the botanical and its specific extract form already appear on the positive list, the importer’s Brazilian partner files a notification with ANVISA. Notification does not involve a pre-market ANVISA assessment, and the product can be marketed once the notification is filed, though ANVISA can request additional information afterward. Notifications need renewal roughly every five years to avoid inactivation.

If the ingredient is not listed, or the specific concentrate or extract form is new to the Brazilian market, it falls under the novel food framework set out in RDC 839/2023. A novel food dossier requires safety and toxicology documentation and typically takes twelve to eighteen months from submission to publication. This is the same structural pattern as the EU Novel Food framework covered in our EU market entry guide, a comprehensive dossier required for anything without a documented history of safe consumption in the destination market before a fixed reference date.

One detail that catches first-time exporters: foreign companies cannot deal with ANVISA directly. A Brazilian-established partner, either a distributor or a dedicated local representative, has to hold the notification or registration and bears legal responsibility for the product in Brazil.

Mexico: no registration, but Spanish-only and permit-per-product

Mexico’s framework, run by the Federal Commission for Protection against Sanitary Risks, COFEPRIS, looks almost inverted next to Brazil’s.

Food supplements, suplementos alimenticios, defined under the General Health Law as herbal products, plant extracts, and concentrates intended to supplement dietary intake, do not require sanitary registration at all. There is no Mexican equivalent of Brazil’s positive list that an ingredient must appear on before it can be sold.

Instead, the importer registers with COFEPRIS through a Notice of Operation, aviso de funcionamiento, and then files a Prior Sanitary Import Permit, an aviso de importacion, for each specific product formulation. COFEPRIS reviews the product’s labeling and ingredient list against a prohibited substances list, things like ephedrine, sibutramine, and certain hormones, rather than checking it against a list of pre-approved botanicals. Processing for a product notice is typically around 20 business days. Herbal extracts including ashwagandha and ginseng are explicitly named as eligible categories by Mexican regulatory consultancies working this process regularly.

The tradeoffs that come with this lighter registration burden:

Labeling must be in Spanish, with NOM-051 governing the required content. English can appear alongside Spanish but cannot substitute for it, and Spanish text must be equal or larger in size. No therapeutic claims are permitted under any circumstances. A separate advertising permit, distinct from the import permit, is required before the product can be marketed, and that typically takes about two months on its own.

Costs for COFEPRIS fees and required lab analysis run roughly 10,000 to 25,000 Mexican pesos and 5,000 to 15,000 pesos per product respectively, before accounting for translation and any regulatory consultant fees.

The trade picture: opposite directions

This is where Brazil and Mexico diverge most sharply, and where suppliers need to be most careful about what they assume.

Mexico raised tariffs on Indian goods in 2026, and raised them again. In December 2025, Mexico approved amendments to its General Import-Export Law raising MFN tariffs by 5 to 50 percent on roughly 1,463 tariff lines, specifically targeting countries without a free trade agreement with Mexico, India among them. That increase took effect January 1, 2026. A second decree in April 2026 added tariffs of 5 to 35 percent on a further 185 tariff lines, covering chemicals, cosmetics, paper, textiles, and several other sectors. India’s government responded to the original increase by opening preferential trade agreement talks with Mexico, since a full free trade agreement would take considerably longer to negotiate than a narrower preferential deal. As of mid-2026, those talks remain at the technical discussion stage, with no concluded agreement.

Whether raw botanical ingredient HS codes are included in either round of tariff increases has not been confirmed. Published sector summaries for both decrees name automotive parts, textiles, plastics, steel and aluminum, footwear, cosmetics, chemicals, paper, furniture, toys, and glass. No sector summary we reviewed names spices, botanical extracts, or herbal ingredients specifically. Sector summaries are not exhaustive line-by-line tariff schedules, so this absence does not confirm botanical HS codes are excluded, only that they are not called out as a named affected category. Before quoting Mexico pricing or signing a contract that assumes a specific duty rate, verify the exact fraccion arancelaria for the product’s HS classification directly with a customs broker, or against the official Mexico TIGIE tariff schedule. This is the single most important verification step in this entire guide.

Brazil’s position with India is comparatively calmer, though not without its own moving parts. Brazil applies its standard MFN tariff schedule to Indian botanical imports, since India does not currently have a preferential trade agreement with Brazil or with Mercosur as a bloc. There is no comparable acute tariff shock on the Brazilian side equivalent to what happened in Mexico starting in 2026.

Quick comparison

	Brazil (ANVISA)	Mexico (COFEPRIS)
Core requirement	Notification if listed; novel food dossier if not	No registration; Notice of Operation plus per-product import permit
Underlying logic	Positive list, ingredient must be authorized	Negative list, ingredient must not be prohibited
Timeline if straightforward	Notification, no fixed pre-market wait	Around 20 business days per product
Timeline if not straightforward	Novel food dossier, 12 to 18 months	Not applicable, no novel ingredient gate
Labeling language	Portuguese	Spanish, mandatory under NOM-051
Foreign company can deal directly with regulator	No, local representative required	No, local importer of record required
Current India trade tariff status	Standard MFN, no preference, no recent shock	Two MFN increases since January 2026, PTA talks ongoing, botanical HS-code treatment unconfirmed

Beyond the two anchors: Colombia, Argentina, Chile

For suppliers planning further into the region once Brazil or Mexico relationships are established:

Colombia, through INVIMA, requires sanitary registration, not just notification, for phytotherapeutic products and dietary supplements. This puts Colombia’s regulatory weight closer to Brazil’s than to Mexico’s permit-based approach, and suppliers should plan for a registration-style timeline rather than a quick notice.

Argentina, through ANMAT, has a consistent reputation among regulatory consultancies as one of the more document-heavy and procedurally complex markets in the region for imports generally, though specific herbal supplement timelines vary by product.

Chile, through the ISP, is generally regarded as comparatively lighter-touch for general consumer products, though Chile is also a smaller market in absolute terms than Brazil, Mexico, or Colombia.

None of these three has a current Indian trade preference comparable to what exists or is being negotiated for Brazil or Mexico, so the trade-status caution that applies to Mexico is not a factor here in the same way, simply because there is no recent preferential or punitive shift to track yet.

What this means for sourcing decisions

If choosing one Latin American market to enter first, the honest tradeoff is this. Brazil has a clearer, if slower, regulatory path once an ingredient is on the positive list, and a calmer trade relationship with India. Mexico has a faster and cheaper regulatory path for most botanicals, paired with a trade relationship that has tightened twice since January 2026 and carries a specific, unresolved detail that needs verification before commercial commitments are made.

Neither market rewards guessing. The positive list in Brazil changes often enough that a check from a year ago is not reliable today. The tariff line schedule in Mexico needs to be confirmed at the HS code level with a customs broker rather than assumed from a sector summary. Both are solvable with a few hours of verification before the first shipment, not after.